Aplastic Anemia
📧 Sign up to get email alerts when something new happens for Aplastic Anemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-02-10FDA Approved: PROMACTA — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for PROMACTA (eltrombopag olamine) submitted by Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia [Phase 1, Phase 2]
This update announces the completion of a Phase 1/2 trial evaluating mesenchymal stem cells for relapsed/refractory severe acquired aplastic…
-
CLINICAL_TRIALS withdrawal · 2014-01-07Clinical Trial Update: Alemtuzumab and Rituximab in Aplastic Anemia [NA]
A clinical trial evaluating alemtuzumab and rituximab in aplastic anemia has been withdrawn.
-
CLINICAL_TRIALS research · 2014-01-06Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia [NA]
This entry discusses donor stem cell transplantation as a treatment option for patients with hematologic cancers, metastatic kidney cancer, …
-
CLINICAL_TRIALS trial_result · 2013-12-24Clinical Trial Update: Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating an unrelated cord blood transplant plus a haplo-identical, T-cell depleted stem cell transplant from a r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia [Phase 2]
Phase 2 clinical trial evaluating umbilical cord blood and placental blood transplantation for hematologic cancers or aplastic anemia. The s…
-
CLINICAL_TRIALS research · 2013-12-11Clinical Trial Update: Study of Non-Myeloablative Haplo-identical Haematopoietic Stem Cell Transplantation in Patients With Haematological Malignancies or Acquired Aplastic Anaemia
This document provides an update on a clinical trial evaluating non-myeloablative haplo-identical hematopoietic stem cell transplantation in…
-
CLINICAL_TRIALS trial_result · 2013-12-03Clinical Trial Update: Different Doses of Anti-thymocyte Globin to Treat Child Severe Aplastic Anemia [Phase 4]
A Phase 4 clinical trial is evaluating different doses of anti-thymocyte globulin to treat children with severe aplastic anemia.
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders [Phase 3]
A Phase 3 multi-center trial evaluating anti-thymocyte globulin for aplastic anemia and related hematologic disorders has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: Moderate-dose Cyclophosphamide for Childhood Acquired Aplastic Anemia [Phase 4]
ClinicalTrials.gov update on a Phase 4 trial evaluating moderate-dose cyclophosphamide for childhood acquired aplastic anemia.
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match [Phase 2]
Phase 2 trial evaluating pooled unrelated donor umbilical cord blood transplant for hematologic malignancies requiring allogeneic stem cell …
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Allogeneic Mixed Chimerism Stem Cell Transplant Using Campath for Hemoglobinopathies & Bone Marrow Failure Syndromes [Phase 2]
Phase 2 trial update of an allogeneic mixed chimerism stem cell transplant using Campath (alemtuzumab) for hemoglobinopathies and bone marro…
-
CLINICAL_TRIALS trial_result · 2013-10-11Clinical Trial Update: Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia [Phase 2]
This Phase 2 clinical trial update reports results from allogeneic stem cell transplantation in patients with severe aplastic anemia; the st…
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: Alemtuzumab and Low-Dose Cyclosporine in Treating Patients With Severe Aplastic Anemia or Acquired Marrow Failure [Phase 2]
Phase 2 clinical trial update evaluating alemtuzumab with low-dose cyclosporine in patients with severe aplastic anemia or acquired marrow f…
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: Treatment of Menorrhagia in Women With Thrombocytopenia Using Platelets or Platelets and Hormones [Phase 1, Phase 2]
A Phase 1/2 trial evaluating platelet transfusions with or without hormones to treat menorrhagia in women with thrombocytopenia was terminat…
-
CLINICAL_TRIALS research · 2013-05-10Clinical Trial Update: Russian Clinical Trial of Mesenchymal Cells in Patients With Septic Shock and Severe Neutropenia [Phase 1, Phase 2]
A Russian Phase 1/2 clinical trial is exploring mesenchymal cell therapy for septic shock and several forms of neutropenia, including drug-i…
-
CLINICAL_TRIALS trial_result · 2013-03-06Clinical Trial Update: Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic Syndrome [Phase 2]
Phase 2 clinical trial evaluating thymoglobulin in combination with cyclosporine in patients with aplastic anemia or myelodysplastic syndrom…
-
CLINICAL_TRIALS trial_result · 2013-01-03Clinical Trial Update: Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Aplastic Anemia [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluated HLA-haploidentical hematopoietic stem cell transplantation in patients with aplastic anemia.
-
CLINICAL_TRIALS trial_result · 2013-01-03Clinical Trial Update: Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013) [Phase 2]
Phase 2 trial evaluating the safety and efficacy of combining levamisole with cyclosporine A in patients with paroxysmal nocturnal hemoglobi…
-
CLINICAL_TRIALS trial_result · 2013-01-03Clinical Trial Update: Haploidentical Stem Cell Transplantation for Children With Acquired Severe Aplastic Anemia [Phase 2]
Phase 2 clinical trial evaluating haploidentical stem cell transplantation in children with acquired severe aplastic anemia.
-
CLINICAL_TRIALS trial_result · 2012-12-11Clinical Trial Update: Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant [Phase 2]
A Phase 2 clinical trial evaluating bone marrow transplantation for patients with severe aplastic anemia or prior transplant rejection has b…
-
CLINICAL_TRIALS trial_result · 2012-12-07Clinical Trial Update: Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor [Phase 2]
Phase 2 study evaluating parathyroid hormone after sequential cord blood transplantation from an unrelated donor; the trial was terminated a…
-
CLINICAL_TRIALS trial_result · 2012-11-09Clinical Trial Update: Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia
This clinical trial evaluated non-myeloablative allogeneic stem cell transplantation with matched unrelated donors across several hematologi…
-
CLINICAL_TRIALS research · 2012-09-07Clinical Trial Update: Comparison of Cy-Atg vs Flu-Atg for the Conditioning Therapy in Allo-HCT for Adult Aplastic Anemia [Phase 3]
Phase 3 clinical trial comparing Cy-ATG versus Flu-ATG conditioning regimens for allogeneic hematopoietic stem cell transplantation in adult…
-
CLINICAL_TRIALS trial_result · 2012-08-09Clinical Trial Update: Antibody Conditioning Regimen For Allogeneic Donor Stem Cell Transplantation Of Patients With Fanconi Anemia [Phase 1, Phase 2]
A phase 1/2 trial evaluating an antibody conditioning regimen for allogeneic donor stem cell transplantation in patients with Fanconi anemia…